Biotechnology News

LOUISVILLE, Colo., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced strategic progress in two collaborative programs for...

Ona Therapeutics advances ONA-255 through Phase 1a and appoints leading oncologist Aleix Prat, MD, PhD as CMO to support its next-generation ADC pipeline.

Flen Health selects AGC Biologics' Heidelberg site for GMP manufacturing of recombinant enzymes supporting U.S. clinical trials in wound care.

德国海德堡, Sept. 24, 2026 (GLOBE NEWSWIRE) -- 比利时生物制药公司 Flen Health 已选择 AGC Biologics 作为 CDMO 合作伙伴，为一款全新改良的伤口及皮肤愈合产品，提供工艺开发、放大和 GMP 生产服务。 生产服务助力监管申报与临床试验 随着 myBIOS 完成细胞系开发，AGC Biologics...

HEIDELBERG, Jerman, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Flen Health, sebuah syarikat biofarmaseutikal dari Belgium, telah melantik AGC Biologics sebagai rakan CDMO strategik mereka. Kerjasama ini...

德國海德堡, Sept. 24, 2026 (GLOBE NEWSWIRE) -- 比利時生物製藥公司 Flen Health 已選定 AGC Biologics 為其 CDMO 合作夥伴，為一款全新改良的傷口及皮膚癒合產品提供製程開發、製程放大及 GMP 生產服務。 製造服務支援監管申請、臨床試驗 隨着 myBIOS 完成細胞株開發，AGC Biologics...

ドイツ・ハイデルベルク発, Sept. 24, 2026 (GLOBE NEWSWIRE) -- ベルギーのバイオ医薬品企業フレン・ヘルス (Flen Health) は、改良された新たな創傷・皮膚治癒製品のプロセス開発、スケールアップ、およびGMP製造サービスを提供するCDMOパートナーとして、AGCバイオロジクス (AGC Biologics) を選定した。 ...

독일 하이델베르크, Sept. 24, 2026 (GLOBE NEWSWIRE) -- 벨기에의 바이오제약기업인 Flen Health가 새롭게 개선된 상처 및 피부 치유 제품의 공정 개발과 스케일업, GMP 제조 서비스를 제공할 위탁개발생산(CDMO) 파트너로 AGC Biologics를 선정했다. 규제기관 제출 및 임상시험 지원 위한 제조 서비스 ...

Final Phase 2a data reinforce the profile of BIOX-101, selected for a late-breaking oral presentation at the World Stroke Congress

19 % reduction in operating expenses compared with the first half of 2025, reflecting the financial discipline of the GroupSolid cash position of €48 million as of June 30, 2026, enabling Carbios to...